+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Duchenne Muscular Dystrophy Market and Competitive Landscape - 2020

  • ID: 5023438
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Duchenne Muscular Dystrophy Market and Competitive Landscape - 2020, provides comprehensive insights into the Duchenne Muscular Dystrophy pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Duchenne Muscular Dystrophy market size and drug sales. It also provides insights into Duchenne Muscular Dystrophy epidemiology and late stage pipeline.

This research covers the following: Duchenne Muscular Dystrophy treatment options, Duchenne Muscular Dystrophy late stage clinical trials pipeline, Duchenne Muscular Dystrophy prevalence by countries, Duchenne Muscular Dystrophy market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Duchenne Muscular Dystrophy pipeline: Find out drugs in clinical trials for the treatment of Duchenne Muscular Dystrophy by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Duchenne Muscular Dystrophy epidemiology: Find out the number of patients diagnosed (prevalence) with Duchenne Muscular Dystrophy by countries
  • Duchenne Muscular Dystrophy drugs: Identify key drugs marketed and prescribed for Duchenne Muscular Dystrophy in the US, including trade name, molecule name, and company
  • Duchenne Muscular Dystrophy drugs sales: Find out the sales value for Duchenne Muscular Dystrophy drugs by countries
  • Duchenne Muscular Dystrophy market valuations: Find out the market size for Duchenne Muscular Dystrophy drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Duchenne Muscular Dystrophy drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Duchenne Muscular Dystrophy drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Duchenne Muscular Dystrophy market
  • Develop in-depth knowledge of competition and markets
  • Analyze Duchenne Muscular Dystrophy drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Duchenne Muscular Dystrophy market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Duchenne Muscular Dystrophy Treatment Options

2. Duchenne Muscular Dystrophy Pipeline Insights
2.1. Duchenne Muscular Dystrophy Phase 3 Clinical Trials
2.2. Duchenne Muscular Dystrophy Phase 2 Clinical Trials
2.3. Duchenne Muscular Dystrophy Phase 1 Clinical Trials

3. Duchenne Muscular Dystrophy Epidemiology Analysis by Countries

4. Germany Duchenne Muscular Dystrophy Market Insights
4.1. Marketed Drugs for Duchenne Muscular Dystrophy in Germany
4.2. Germany Duchenne Muscular Dystrophy Market Size & Forecast
4.3. Germany Duchenne Muscular Dystrophy Drugs Sales Forecast
4.4. Germany Duchenne Muscular Dystrophy Market Share Analysis

5. France Duchenne Muscular Dystrophy Market Insights
5.1. Marketed Drugs for Duchenne Muscular Dystrophy in France
5.2. France Duchenne Muscular Dystrophy Market Size & Forecast
5.3. France Duchenne Muscular Dystrophy Product Sales Forecast
5.4. France Duchenne Muscular Dystrophy Market Share Analysis

6. Italy Duchenne Muscular Dystrophy Market Insights
6.1. Marketed Drugs for Duchenne Muscular Dystrophy in Italy
6.2. Italy Duchenne Muscular Dystrophy Market Size & Forecast
6.3. Italy Duchenne Muscular Dystrophy Product Sales Forecast
6.4. Italy Duchenne Muscular Dystrophy Market Share Analysis

7. Spain Duchenne Muscular Dystrophy Market Insights
7.1. Marketed Drugs for Duchenne Muscular Dystrophy in Spain
7.2. Spain Duchenne Muscular Dystrophy Market Size & Forecast
7.3. Spain Duchenne Muscular Dystrophy Product Sales Forecast
7.4. Spain Duchenne Muscular Dystrophy Market Share Analysis

8. UK Duchenne Muscular Dystrophy Market Insights
8.1. Marketed Drugs for Duchenne Muscular Dystrophy in UK
8.2. UK Duchenne Muscular Dystrophy Market Size & Forecast
8.3. UK Duchenne Muscular Dystrophy Product Sales Forecast
8.4. UK Duchenne Muscular Dystrophy Market Share Analysis

9. Europe Duchenne Muscular Dystrophy Market Insights
9.1. Europe Duchenne Muscular Dystrophy Market Size & Forecast
9.2. Europe Duchenne Muscular Dystrophy Product Sales Forecast
9.3. Europe Duchenne Muscular Dystrophy Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Duchenne Muscular Dystrophy Phase 3 Clinical Trials, Global, 2020
Table 2: Duchenne Muscular Dystrophy Phase 2 Clinical Trials, Global, 2020
Table 3: Duchenne Muscular Dystrophy Phase 1 Clinical Trials, Global, 2020
Table 4: Duchenne Muscular Dystrophy Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Duchenne Muscular Dystrophy in Germany, 2019
Table 6: Germany Duchenne Muscular Dystrophy Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Duchenne Muscular Dystrophy Product Sales ($mn), 2016 - 2024
Table 8: Germany Duchenne Muscular Dystrophy Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Duchenne Muscular Dystrophy in France, 2019
Table 10: France Duchenne Muscular Dystrophy Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Duchenne Muscular Dystrophy Product Sales ($mn), 2016 - 2024
Table 12: France Duchenne Muscular Dystrophy Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Duchenne Muscular Dystrophy in Italy, 2019
Table 14: Italy Duchenne Muscular Dystrophy Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Duchenne Muscular Dystrophy Product Sales ($mn), 2016 - 2024
Table 16: Italy Duchenne Muscular Dystrophy Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Duchenne Muscular Dystrophy in Spain, 2019
Table 18: Spain Duchenne Muscular Dystrophy Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Duchenne Muscular Dystrophy Product Sales ($mn), 2016 - 2024
Table 20: Spain Duchenne Muscular Dystrophy Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Duchenne Muscular Dystrophy in UK, 2019
Table 22: UK Duchenne Muscular Dystrophy Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Duchenne Muscular Dystrophy Product Sales ($mn), 2016 - 2024
Table 24: UK Duchenne Muscular Dystrophy Market Events and Trends, 2016 - 2024
Table 25: Europe Duchenne Muscular Dystrophy Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Duchenne Muscular Dystrophy Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Duchenne Muscular Dystrophy Pipeline by Phase (%), Global, 2020
Figure 2: Duchenne Muscular Dystrophy Prevalence by Countries, 2016 - 2024
Figure 3: Germany Duchenne Muscular Dystrophy Market Size ($mn), 2016 - 2024
Figure 4: Germany Duchenne Muscular Dystrophy Product Sales ($mn), 2016 - 2024
Figure 5: Germany Duchenne Muscular Dystrophy Market Share by Drugs (%), 2019
Figure 6: Germany Duchenne Muscular Dystrophy Market - Future Market Share (%), 2024
Figure 7: France Duchenne Muscular Dystrophy Market Size ($mn), 2016 - 2024
Figure 8: France Duchenne Muscular Dystrophy Product Sales ($mn), 2016 - 2024
Figure 9: France Duchenne Muscular Dystrophy Market Share by Drugs (%), 2019
Figure 10: France Duchenne Muscular Dystrophy Market - Future Market Share (%), 2024
Figure 11: Italy Duchenne Muscular Dystrophy Market Size ($mn), 2016 - 2024
Figure 12: Italy Duchenne Muscular Dystrophy Product Sales ($mn), 2016 - 2024
Figure 13: Italy Duchenne Muscular Dystrophy Market Share by Drugs (%), 2019
Figure 14: Italy Duchenne Muscular Dystrophy Market - Future Market Share (%), 2024
Figure 15: Spain Duchenne Muscular Dystrophy Market Size ($mn), 2016 - 2024
Figure 16: Spain Duchenne Muscular Dystrophy Product Sales ($mn), 2016 - 2024
Figure 17: Spain Duchenne Muscular Dystrophy Market Share by Drugs (%), 2019
Figure 18: Spain Duchenne Muscular Dystrophy Market - Future Market Share (%), 2024
Figure 19: UK Duchenne Muscular Dystrophy Market Size ($mn), 2016 - 2024
Figure 20: UK Duchenne Muscular Dystrophy Product Sales ($mn), 2016 - 2024
Figure 21: UK Duchenne Muscular Dystrophy Market Share by Drugs (%), 2019
Figure 22: UK Duchenne Muscular Dystrophy Market - Future Market Share (%), 2024
Figure 23: Europe Duchenne Muscular Dystrophy Market Size ($mn), 2016 - 2024
Figure 24: Europe Duchenne Muscular Dystrophy Product Sales ($mn), 2016 - 2024
Figure 25: Europe Duchenne Muscular Dystrophy Market Share by Drugs (%), 2019
Figure 26: Europe Duchenne Muscular Dystrophy Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll